XML 55 R38.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation The following table presents the amount of stock-based compensation related to stock-based awards to employees on the Company’s consolidated statements of operations and comprehensive loss during the years ended December 31, 2022 and 2021 (in thousands):
20222021
Research and development$2,856 $2,233 
Sales and marketing456 213 
General and administrative8,577 5,476 
Total stock-based compensation$11,889 $7,922 
Schedule of Share-based Payment Arrangement, Option, Activity
Stock option and RSU activity, prices, and values during the years ended December 31, 2022 and 2021 are as follows (in thousands, except for share, per share, and contractual term data):
Options OutstandingRSUs
Number of
shares
Weighted
average
exercise price
Weighted
average
remaining
 contractual
term
(years)
Aggregate
intrinsic
values
($’000s)
Number of plan shares outstandingWeighted average
grant date fair value
per share
Balances at December 31, 2020
5,732,422 $0.30 8.23$4,333 — $— 
Options and RSUs granted1,454,549 1.75 3,392,153 10.69 
Options exercised and RSUs released(2,496,070)0.27 — — 
Options and RSUs forfeited(894,371)0.46 — — 
Balances as of December 31, 2021
3,796,530 $0.83 8.08$40,274 3,392,153 $10.69 
Options and RSUs granted65,717 8.00 5,602,206 4.68 
Options exercised and RSUs released(529,832)4.28 (1,526,784)8.02 
Options and RSUs forfeited(109,306)2.53 (1,120,620)10.46 
Balances as of December 31, 2022
3,223,109 $1.01 7.39$4,583 6,346,955 $6.10 
Options vested and exercisable - December 31, 2021
1,827,374 $0.31 7.20$20,337 
Options vested and exercisable - December 31, 2022
1,947,123 $0.76 7.06$3,244 
Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity
Stock option and RSU activity, prices, and values during the years ended December 31, 2022 and 2021 are as follows (in thousands, except for share, per share, and contractual term data):
Options OutstandingRSUs
Number of
shares
Weighted
average
exercise price
Weighted
average
remaining
 contractual
term
(years)
Aggregate
intrinsic
values
($’000s)
Number of plan shares outstandingWeighted average
grant date fair value
per share
Balances at December 31, 2020
5,732,422 $0.30 8.23$4,333 — $— 
Options and RSUs granted1,454,549 1.75 3,392,153 10.69 
Options exercised and RSUs released(2,496,070)0.27 — — 
Options and RSUs forfeited(894,371)0.46 — — 
Balances as of December 31, 2021
3,796,530 $0.83 8.08$40,274 3,392,153 $10.69 
Options and RSUs granted65,717 8.00 5,602,206 4.68 
Options exercised and RSUs released(529,832)4.28 (1,526,784)8.02 
Options and RSUs forfeited(109,306)2.53 (1,120,620)10.46 
Balances as of December 31, 2022
3,223,109 $1.01 7.39$4,583 6,346,955 $6.10 
Options vested and exercisable - December 31, 2021
1,827,374 $0.31 7.20$20,337 
Options vested and exercisable - December 31, 2022
1,947,123 $0.76 7.06$3,244 
Schedule of Valuation Assumptions
In accordance with ASC 718, the fair value of each option grant has been estimated as of the date of grant using the following weighted average assumptions:
20222021
Risk-free rate1.64 %1.01 %
Expected volatility73.95 %75.14 %
Expected term6 years6 years
Expected dividends— —